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Introduction
Several human body districts are colonized by a microbial 
community and the gathering of these pools makes up the 
microbiota. This huge population is formed by bacteria, fungi and 
these microorganisms are extimed to outnumber human cells [1-
3]. Human physiological status greatly depends on microbiota, 
in fact it presence is necessary for a normal development, as 
well as for supporting immune system in the protection of the 
host from pathogens [4,5]. Intestinal microbiota’s relevance in 
pathogenesis of HCV-induced chronic liver diseases is a rising 
topic among scientific community. Anyway, its role in chronic 
hepatitis C virus (HCV) infection is still unclear and it needs 
more focused studies [6]. Microbiota nutritionally competes 
with pathogens for resources and colonization sites and it gives 
fundamental signals for immune priming, sustaining immune 
system correct development [7-10]. It has a controversial role, 
since it can limit or promote viral infection, or have no effect, 
but direct or indirect effects on viral infection itself can take 
place. For example, microbiota (or its metabolites) may interact 
with viral particles, altering response or infectivity [11-14]. 
Intestinal microbiota has also been recognized to have a pivotal 
importance in autoimmune diseases such as type 1 diabetes 
(T1D) [15-17]. The aim of this short review is to reassume the 
state of the art of microbiota/HCV interactions and possibily 
give a novel point of view based on the reviewed studies, using 
an eagle-eye perspective.
The HCV infection
Hepatitis C virus (HCV) is held responsible for about 17.5% 
of acute hepatitis cases and it was reported that, after acute 
 
infection, roughly 65% of patients develops a chronic infection 
[18]. According to the WHO (World Health Organization) 
statistics, HCV is currently infecting about 170 million people 
worldwide. Patients suffering from Chronic Hepatitis C (CHC) 
have a high probability to develop serious complications, i.e. 
cirrhosis and hepatocellular carcinoma (HCC) [19-21]. Under 
an epidemiological point of view, it was reported that HCV is 
associated with several extrahepatic manifestations such as type 
2 diabetes mellitus, insulin resistance, oral manifestations and 
glomerulopathies [22-25].
Microbiota and viral infections
Since microbiota typically colonizes sites used by viruses 
to introduce their selves into hosts, its presence can is some 
cases affect the infection outcome. It was in fact reported that 
the commensal microbiota of Aedes aegypti (an insect vector) 
indirectly mitigates Dengue viral transmission [26]. Mosquitoes 
in which the commensal population is killed by antibiotic 
molecules show higher viral titers with the respect to those in 
which antibiotics are not administered. Moreover, mosquitoes 
having their natural microbial population highly express a 
broad set of immune-related genes, such as those encoding 
antimicrobial peptides modulated by Toll-like receptor (TLR) 
pathway (Xi et al. 2008).
On the other hand, while it is true that microbiota can be 
pivotal to fight viral infections and therefore shift the infective 
process balance, it may also enhance viral infection, either in 
a direct or indirect way. Previous studies demonstrated the 
indirect promoting activity exerted by microbiota on virus 
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replication, i.e. the viral infection enhancing via the proliferative 
stimulation or target cells activation [27]. Moreover, this concept 
is especially applicable for retroviruses targeting proliferating 
cells, in fact, murine leukemia virus (MuLV)-infected germ-free 
mice are show a mild resistance to virally induced leukemia if 
compared to conventional murine models [28,29]. Conversely, 
sheep red blood cells-immunized MuLV-infected mice show a 
significant increase in leukemia development, comparable to 
that of infected specific pathogen free (SPF) mice [29]. Previous 
investigations show that viruses belonging to three distinct 
families partially depend on commensal microorganisms in 
order to perform an efficient replication/transmission process 
[30,31]. Kuss et al. [30] demonstrated that poliovirus-susceptible 
mice administered with antibiotics exhibit lower mortality 
rates after poliovirus infection if compared to untreated ones. 
Relevantly, virus replication in murine guts is highly relying on 
microbiota, in fact antibiotic-treated and germ-free mice secrete 
poorly virulent viruses. Both Gram-positive and Gram-negative 
bacteria incubated with poliovirus highly promote its infectivity 
in cultured cells. Such a phenomenon does not need live bacteria, 
because surface polysaccharides, like peptidoglycan (PG) and 
lipopolysaccharides (LPS), are sufficient to exert such an effect 
on viral infectivity. Significantly, these results were not solely 
related to poliovirus, since the reovirus infection was found to 
be more severe if gut microbial population were present.
HCV and microbiota
To date, Pubmed Archive (www.ncbi.nlm.nih.gov/pubmed/) 
reports few researches on relations standing between HCV and 
microbiota have been published. Yet, this interplay was not fully 
understood. One of the most recent published studies reported 
that intestinal microbiota of 95 patients chronically infected 
with HCV, with and without cirrhosis, greatly differs between 
cirrhotic and non-cirrhotic patients. Moreover, this study 
highlighted that the stage of both HCV infection and liver disease 
is linked with a lowered alpha diversity, and it was inferred that 
this could be due to a direct cross-talk between HCV and host’s 
bacterial populations or indirect relations enhanced by immune 
system [32]. So, this is an example in which microbiota could 
be held responsible of easing both viral activity once patient is 
infected and stage of cirrhosis. So, phylotypes number appear to 
be inversely proportional to the occurred complications.
Interestingly, it was demonstrated that mucosal gut 
microbiota composition is altered in patients with Chronic 
Hepatitis C (CHC) with respect to cirrhotic ones and those 
suffering from hepatocellular carcinoma (HCC). An increase of 
Proteobacteria and a reduction of Bacteroidetes and Firmicutes 
phyla was reported in CHC, HCC and cirrhotic individuals, 
suggesting the existence a pathogenic role of gut microbiota 
in the HCV-related liver disease and HCC development [33]. 
So, in this case, a precise unbalance in bacterial populations is 
correlated with the virus and is long-term complications. Thus, 
it can be said that preservation of gut microbiota composition, 
employing various strategies like prebiotics and probiotics 
seems to be a hopeful instrument for preventing or treating 
the progress of liver disorders associated with HCV [34-36]. 
Interestingly, stool samples analyses from six HCV patients and 
eight healthy individuals gene sequencing showed that the alpha-
diversity of the healthy individuals gut microbiomes was higher 
than the patients one. Common points with the above cited 
work can be found, in fact, although Bacteroidetes were more 
abundant in HCV subjects, healthy ones had more Firmicutes, 
Proteobacteria, and Actinobacteria. Moreover, Bifidobacterium 
(probiotic genus), was only detected in healthy individuals [37]. 
Plus, a cohort of 105 HCV cirrhotics was examined in order to 
understand if viral eradication could impact on microbiota 
composition. No significant differences in overall microbiota 
diversity (UNIFRAC P=0.3) between groups with/without 
SVR (Sustained Virological Response). So, curing the infection 
does not bring any variation in gut microbiome [38]. However, 
results about microbiota analysis of a large population of HCV 
individuals are lacking.
Conclusion
It can be concluded that, although researches on relationships 
standing between human microbiota and HCV infections are 
lacking, the few published papers are highly inspirational for 
both further studies and theoretical investigations. As stated 
above, HCV infection and related liver disorders are influenced 
by microbiota, namely by loss of bacterial composition balance 
and lowering of phylotypes diversity. Taken together, these 
findings allow to point out that the gut-liver axis is very 
important within the HCV infection context and is particularly 
influential on its liver complication. It could be therefore useful 
to perform fecal transplantations on patients that are found in a 
condition of gut dysbiosis, in order to restore the phyla pattern. 
It remains unclear if particular microbiota alterations could 
act as a predisposing factor for an especially aggressive HCV 
infection or if such an infection causes dysbiosis. 
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